Ranbaxy falls over 30 pct after FDA import alert
Shares in Ranbaxy Laboratories Ltd dropped more than 30 percent, after the U.S. Food and Drug Administration issued an import alert against company's Mohali plant.
READ MORE:
Other Stocks Videos
Biocon to sell stake in biosimilar arm and Syngene: Sources
Stocks in news: Lupin, GMR Airports and more
Stocks in news: United Breweries, Tata Motors, Mazagon Dock and more
Manipal's Ranjan Pai acquires Rs 1,400 crore Davidson Kempner debt on BYJU's
Samvat 2080: 80 stock recommendations from top brokerage houses for your portfolio this new year
